ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 665899 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 665899; 2) Community: the network communities that were significantly associated with the response to NSC 665899; 3) Molecule: the relationships between components within communities and NSC 665899; 4) MDR: the compounds that were significantly associated with the NSC 665899.

NSC Compound Enrichment Correlation
NSC 744989 7-methoxy-8-[(5-2-methoxy-4-[(E)-3-(2,4-dimethyl-3-quinolyl)-3-oxo-1-propenyl]phenoxybutyl)oxy]-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-5-one 0.0291420747327558 -0.038170461
NSC 762 Mechlorethamine 0.0291420747327558 0.2888298
NSC 105132 Deoxycamptothecin 0.029142074732756 0.17638375
NSC 128635 Null 0.029142074732756 0.15012295
NSC 132275 Ethanesulfonic acid, compd. with 2-(2-chloro-4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenoxy)acetanilide (1:1) 0.029142074732756 0.12793945
NSC 166199 Phosphinic amide, P,P-bis(1-aziridinyl)-N-tricyclo[3.3.1.1(3.7)]dec-1-yl- (9CI) 0.029142074732756 0.20475642
NSC 176323 Camptothecin Derivative 0.029142074732756 0.15238374
NSC 319947 2,4-Pyrimidinediamine, 5-(3-azido-4-chlorophenyl)-6-ethyl- 0.029142074732756 0.27778732
NSC 330507 Tanespimycin 0.029142074732756 -0.0043283036
NSC 616960 2[5H]-Furanone, 5-[(.beta.-D-glucopyranosyloxy)methyl]-,(S)- (9CI) 0.029142074732756 0.29253722
Total:53  Current:31    [First] [Prev] [Next] [Last]